akdae.de
An independent medicines commission providing drug safety information and evidence-based therapy guidance for German physicians
About akdae.de
The Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) advises on rational medicines therapy and drug safety. It publishes therapy recommendations and an independent medicines bulletin, and collects reports of adverse drug reactions.
AkdÄ is a standing specialist committee of the German Medical Association. Its work includes collaboration with the Federal Institute for Drugs and Medical Devices on medicines safety and continuing medical education for physicians.
Product: Medicines safety information, adverse drug reaction reporting, therapy recommendations, and publications for physicians.
Jobs at akdae.de
More health & medtech companies
Aktivital
Corporate health management and employee development services for businesses and public-sector organizationsNew on EvolcRemote-friendlySalary transparentalber.de
Electric wheelchair drives, foldable power wheelchairs and push aids for wheelchair users and their companionsNew on Evolcalexianer.de
Catholic healthcare group providing hospitals, care and support services across GermanyNew on Evolcallergiecheck.de
German-language allergy information portal helping people find specialists and manage allergy symptomsNew on Evolcalloheim.de
Residential and home-based care services for older adults and people needing care across GermanyAlmavita
Residential care homes providing accommodation and nursing care for older adults in GermanyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- TYPO3High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Site generatormeta generator
- Site generatormeta generator
- Site generatormeta generator
Privacy & consent
- CookiebotHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.